Granules India’s arm gets USFDA’s nod for Valganciclovir Hydrochloride for Oral Solution

05 Feb 2020 Evaluate

Granules India’s wholly owned foreign subsidiary -- Granules Pharmaceuticals, Inc., has received approval from US Food & Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) for Valganciclovir Hydrochloride for oral solution, 50 mg/mL. It is bioequivalent to the reference listed drug product (RLD), Valcyte for oral solution, 50 mg/mL, of Roche Palo Alto LLC. Valganciclovir Hydrochloride solution is an antiviral medication used to treat cytomegalovirus infections.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Granules India Share Price

605.90 -2.90 (-0.48%)
09-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1826.10
Dr. Reddys Lab 1371.60
Cipla 1488.15
Lupin 2251.80
Zydus Lifesciences 1009.40
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.